Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys

Barouch, Dan H.; Alter, Galit; Broge, Thomas; Linde, Caitlyn; Ackerman, Margaret E.; Brown, Eric P.; Borducchi, Erica N.; Smith, Kiersten S.; Nkolola, Joseph P.; Liu, Jinyan; Shields, Jennifer L.; Parenteau, Lily; Whitney, James B.; Abbink, Peter; Ng’ang’a, David; Seaman, Michael S.; Lavine, Christy L.; Perry, James; Li, Wenjun; Colantonio, Arnaud D.; Lewis, Mark G.; Chen, Bing; Wenschuh, Holger; Reimer, Ulf; Piatak, Michael; Lifson, Jeffrey D.; Handley, Scott A.; Virgin, Herbert W.; Koutsoukos, Marguerite; Lorin, Clarisse; Voss, Gérald; Weijtens, Mo; Pau, Maria Grazia; Schuitemaker, Hanneke

doi:10.1126/science.aab3886

Cited by 273 publications

(330 citation statements)

References 36 publications

Supporting

Mentioning

309

Contrasting

Unclassified

Order By: Relevance

“…The same concerns apply to other uncleaved gp140s of comparable designs that are also being produced for clinical trials, again on the basis that they mimic the native structure of virion-associated Env (36,82). A more appropriate rationale for the use of uncleaved gp140s may be their induction of non-NAbs that are partially protective in a macaque challenge model (83). Having said that, it is notable that nonNAbs are clearly very substantially less effective than bNAbs at conferring protection in macaque passive transfer experiments (84)(85)(86).…”

Section: Discussionmentioning

confidence: 99%

Influences on the Design and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers

Ringe

Yasmeen

Ozorowski

et al. 2015

J Virol

166

View full text Add to dashboard Cite

We have investigated factors that influence the production of native-like soluble, recombinant trimers based on the env genes of two isolates of human immunodeficiency virus type 1 (HIV-1), specifically 92UG037.8 (clade A) and CZA97.012 (clade C). When the recombinant trimers based on the env genes of isolates 92UG037.8 and CZA97.012 were made according to the SOSIP.664 design and purified by affinity chromatography using broadly neutralizing antibodies (bNAbs) against quaternary epitopes (PGT145 and PGT151, respectively), the resulting trimers are highly stable and they are fully native-like when visualized by negative-stain electron microscopy. They also have a native-like (i.e., abundant) oligomannose glycan composition and display multiple bNAb epitopes while occluding those for nonneutralizing antibodies. In contrast, uncleaved, histidine-tagged Foldon (Fd) domain-containing gp140 proteins (gp140 UNC -Fd-His), based on the same env genes, very rarely form native-like trimers, a finding that is consistent with their antigenic and biophysical properties and glycan composition. The addition of a 20-residue flexible linker (FL20) between the gp120 and gp41 ectodomain (gp41 ECTO ) subunits to make the uncleaved 92UG037.8 gp140-FL20 construct is not sufficient to create a native-like trimer, but a small percentage of native-like trimers were produced when an I559P substitution in gp41 ECTO was also present. The further addition of a disulfide bond (SOS) to link the gp120 and gp41 subunits in the uncleaved gp140-FL20-SOSIP protein increases native-like trimer formation to ϳ20 to 30%. Analysis of the disulfide bond content shows that misfolded gp120 subunits are abundant in uncleaved CZA97.012 gp140 UNC -Fd-His proteins but very rare in native-like trimer populations. The design and stabilization method and the purification strategy are, therefore, all important influences on the quality of trimeric Env proteins and hence their suitability as vaccine components. IMPORTANCESoluble, recombinant multimeric proteins based on the HIV-1 env gene are current candidate immunogens for vaccine trials in humans. These proteins are generally designed to mimic the native trimeric envelope glycoprotein (Env) that is the target of virus-neutralizing antibodies on the surfaces of virions. The underlying hypothesis is that an Env-mimetic protein may be able to induce antibodies that can neutralize the virus broadly and potently enough for a vaccine to be protective. Multiple different designs for Env-mimetic trimers have been put forth. Here, we used the CZA97.012 and 92UG037.8 env genes to compare some of these designs and determine which ones best mimic virus-associated Env trimers. We conclude that the most widely used versions of CZA97.012 and 92UG037.8 oligomeric Env proteins do not resemble the trimeric Env glycoprotein on HIV-1 viruses, which has implications for the design and interpretation of ongoing or proposed clinical trials of these proteins. R ecombinant, soluble envelope glycoprotein (Env) gp140 trimers from...

show abstract

Section: Discussionmentioning

confidence: 99%

Influences on the Design and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers

Ringe

Yasmeen

Ozorowski

et al. 2015

J Virol

166

View full text Add to dashboard Cite

show abstract

“…114 Furthermore, Ad26 mosaic prime and gp140 boost was associated with 40% protection after 6 intrarectal challenges in RM. 115 HIV-V-A002 (NCT02218125), a phase I study of MVA mosaic vaccine in 25 participants in the USA has recently been completed. HIV-V-A004 (NCT02315703), an international phase I study using Ad26 mosaic vectors prime, followed by boosting with Ad26 or MVA mosaic vectors and/or high, low or no clade C gp140 in 394 volunteers is at the final data collection stage (Table 2).…”

Section: Mosaic Vaccinementioning

confidence: 99%

Progress in HIV vaccine development

Hsu

O’Connell

2017

Human Vaccines & Immunotherapeutics

View full text Add to dashboard Cite

“…Recent evidence suggests that functional antibodies to Env are necessary and sufficient to significantly reduce the probability of infection by SIV in non-human primates. Although the nonhuman primate sera against Env exhibited mild in vitro neutralization, they showed enhanced antibody effector functions in non-human primates (22,23).…”

mentioning

confidence: 99%

Structure-based Design of Cyclically Permuted HIV-1 gp120 Trimers That Elicit Neutralizing Antibodies

Kesavardhana

Das

Citron

et al. 2017

Journal of Biological Chemistry

View full text Add to dashboard Cite

A major goal for HIV-1 vaccine development is an ability to elicit strong and durable broadly neutralizing antibody (bNAb) responses. The trimeric envelope glycoprotein (Env) spikes on HIV-1 are known to contain multiple epitopes that are susceptible to bNAbs isolated from infected individuals. Nonetheless, all trimeric and monomeric Env immunogens designed to date have failed to elicit such antibodies. We report the structure-guided design of HIV-1 cyclically permuted gp120 that forms homogeneous, stable trimers, and displays enhanced binding to multiple bNAbs, including VRC01, VRC03, VRC-PG04, PGT128, and the quaternary epitope-specific bNAbs PGT145 and PGDM1400. Constructs that were cyclically permuted in the V1 loop region and contained an N-terminal trimerization domain to stabilize V1V2-mediated quaternary interactions, showed the highest homogeneity and the best antigenic characteristics. In guinea pigs, a DNA prime-protein boost regimen with these new gp120 trimer immunogens elicited potent neutralizing antibody responses against highly sensitive Tier 1A isolates and weaker neutralizing antibody responses with an average titer of about 115 against a panel of heterologous Tier 2 isolates. A modest fraction of the Tier 2 virus neutralizing activity appeared to target the CD4 binding site on gp120. These results suggest that cyclically permuted HIV-1 gp120 trimers represent a viable platform in which further modifications may be made to eventually achieve protective bNAb responses.The HIV-1 Env displayed on the virion surface mediates entry of the virion into target CD4 ϩ T cells to establish infection. Due to its surface accessibility, Env is the predominant target for neutralizing antibody responses (1, 2). Env is synthesized as a gp160 precursor protein, which is further cleaved into surface proximal gp120 and membrane anchored gp41 subunits. A functional HIV-1 Env spike consists of a trimer of gp120 and gp41 heterodimers. The base of the trimer is proximal to the viral membrane (3) and is held together by trimerization motifs within the N-heptad repeat of gp41 (4 -6). The trimer apex is stabilized by interactions between the V1V2 loops of adjacent gp120 monomers (3). Binding of Env to the CD4 receptor on T cells causes extensive conformational changes in the Env trimer and leads to the formation of an open CD4-bound conformation in which the cryptic, co-receptor binding site becomes accessible. This facilitates interaction of the co-receptor (CCR5 or CXCR4) with Env, further driving the fusion of viral and host cell membranes (3, 7).In natural HIV-1 infection, most of the B cell response is elicited against the Env protein, due to its location on the virion surface and relatively high immunogenicity. The antibody response induced during natural HIV-1 infection is predominantly non-neutralizing and strain specific, due to the shed gp120 (immunodominant decoys) and various other immune evasive mechanisms (8). However, ϳ20% of HIV-1-infected patients develop bNAbs during the course of 1-3 years of infectio...

show abstract

Protective efficacy of adenovirus/protein vaccines against SIV challenges in rhesus monkeys

Cited by 273 publications

References 36 publications

Influences on the Design and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers

Influences on the Design and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers

Progress in HIV vaccine development

Structure-based Design of Cyclically Permuted HIV-1 gp120 Trimers That Elicit Neutralizing Antibodies

Contact Info

Product

Resources

About